NEURONETICS INC (STIM) Stock Analyst Ratings
USA - NASDAQ:STIM - US64131A1051 - Common Stock
2.69 USD
-0.19 (-6.6%)
2.7 USD
+0.01 (+0.37%)
ChartMill assigns a Buy % Consensus number of 82% to STIM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.63. This target is 146.47% above the current price.
STIM was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about STIM.
In the previous month the buy percentage consensus was at a similar level.
STIM was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-05 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-03-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-12 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-05-14 | William Blair | Upgrade | Market Perform -> Outperform |
| 2024-03-06 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2023-05-10 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-08 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-08 | Canaccord Genuity | Maintains | Buy |
| 2021-10-14 | JMP Securities | Maintains | Market Outperform |
| 2021-10-13 | BTIG | Downgrade | Buy -> Neutral |